drugset / Trial / NCT06693960
Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach
Phase 0
Recruiting
16 enrolled
Washington State University
National Center for Complementary and Integrative Health (NCCIH) · collabOffice of Dietary Supplements (ODS) · collab
Non-randomizedCrossoverOpen-labelBasic science
Summary
The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
Timeline
- Start
- 2024-09-26
- Primary completion
- 2026-12-15
- Completion
- 2027-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | 100 mg | Oral |
| Subject | Dextromethorphan | Unknown | 30 mg | Oral |
| Subject | Losartan | Other / unclassified | 25 mg | Oral |
| Subject | Midazolam | Small molecule | 2 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |
Indications
No indication recorded.